Friday - March 13, 2026
BMJ Group: Wegovy May Have Highest 'eye Stroke' and Sight Loss Risk of Semaglutide GLP-1 Agonists
March 12, 2026
LONDON, England, March 12 (TNSjou) -- BMJ Group issued the following news release about British Journal of Ophthalmology:

* * *

Wegovy may have highest 'eye stroke' and sight loss risk of semaglutide GLP-1 agonists

Odds of ischaemic optic neuropathy nearly 5 times higher than among users of Ozempic

And 3 times higher in men than in women, analysis of unintended side effect reports shows

*

Wegovy, a GLP-1 ago . . .

Targeted News Service Document Request Form

This document is available to you by e-mail if you complete the form below with relevant information. There may be a fee for this article or ongoing service of similar materials. We will be in touch shortly.

Name:
What's your
Affiliation		 Government Newspaper / Media Business
Public Policy Individual / Student Educators
Email:
Phone:
Organization, if any:
State/Country you are in:
Additonal questions
or comments:

Click here for more information about our products

Click here for more information about our products